Lataa...
Osteoporosis Treatment with Anti-Sclerostin Antibodies—Mechanisms of Action and Clinical Application
Osteoporosis is characterized by reduced bone mass and disruption of bone architecture, resulting in increased risk of fragility fractures and significant long-term disability. Although both anti-resorptive treatments and osteoanabolic drugs, such as parathyroid hormone analogues, are effective in f...
Tallennettuna:
| Julkaisussa: | J Clin Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920044/ https://ncbi.nlm.nih.gov/pubmed/33669283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040787 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|